GovBidAlerts
← All opportunities

TRICARE Pharmacy Program RFI (Draft Section C & H)

Key dates

Posted
Apr 21, 2026
Response deadline
May 22, 2026, 6:00 PM UTC
Archive date
Archive type
auto15

Classification

Notice type
Special Notice
Base type
Special Notice
Set-aside
Set-aside code
PSC
Q201

NAICS

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE HEALTH AGENCY (DHA)
Office
DEFENSE HEALTH AGENCY
Office code
Organization type
OFFICE
Office address
AURORA, CO, 80011, USA

Contacts

Description

The Defense Health Agency (DHA) is in the acquisition planning phase for the next generation TRICARE Pharmacy Program (TPharm6) contract. These draft documents are provided for industry’s feedback and refinement. The Government invites qualified vendors to submit feedback and questions on the following draft documents: Section C, Statement of Work Section H, Special Contract Requirements The DHA will facilitate one-on-one meetings with industry to gather additional feedback and answer questions related to the draft documents in the summer of 2026. Please follow the instructions below to request a one-on-one meeting and to submit questions, comments, or general feedback. Instructions Comments and questions specific to Section C and Section H must be submitted no later than May 22, 2026 at 12:00PM Mountain Time to dha.buckley.AD-SPT-CAE.mbx.tpharm6@health.mil. Include in the email subject line the following: Your Company Name and Draft Documents Response. One-On-One Meetings: Requests for a one-on-one meeting with the DHA related to TPharm6 can be made using the link - https://forms.osi.apps.mil/r/zBn9EyRm0g. The request for one-on-one meeting attendance must be submitted no later than May 22, 2026 at 12:00PM Mountain Time.

Similar open contracts

Metadata

Notice ID
09ca7ec9fa2a40cba7cac54e169a5b7f
Full path
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
Office code
Ingested
May 2, 2026
Updated
May 3, 2026